Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

Open Label ◽

Phase 3

Faculty Opinions recommendation of Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697919.793454600 ◽

2012 ◽

Author(s):

Yiqian Nancy You ◽

Brian Keith Bednarski

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 3 ◽

Faculty Opinions recommendation of Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697919.793152987 ◽

2012 ◽

Cited By ~ 1

Author(s):

Mitesh Borad

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 3 ◽

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00079-6 ◽

2021 ◽

Cited By ~ 1

Author(s):

Thierry Conroy ◽

Jean-François Bosset ◽

Pierre-Luc Etienne ◽

Emmanuel Rio ◽

Éric François ◽

...

Keyword(s):

Rectal Cancer ◽

Neoadjuvant Chemotherapy ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Open Label ◽

Phase 3 ◽

Open Label Phase

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70187-0 ◽

2012 ◽

Vol 13 (7) ◽

pp. 679-687 ◽

Cited By ~ 393

Author(s):

Claus Rödel ◽

Torsten Liersch ◽

Heinz Becker ◽

Rainer Fietkau ◽

Werner Hohenberger ◽

...

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 3 ◽

Faculty Opinions recommendation of Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697919.793454533 ◽

2012 ◽

Author(s):

Josep Tabernero ◽

Elena Elez

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 3 ◽

Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine +/- Oxaliplatin in Locally Advanced Rectal Cancer: Interim Analysis for Disease-Free Survival of Petacc 6

Annals of Oncology ◽

10.1093/annonc/mdu333.8 ◽

2014 ◽

Vol 25 ◽

pp. iv170 ◽

Cited By ~ 1

Author(s):

H.J. Schmoll ◽

K. Haustermans ◽

T.J. Price ◽

B. Nordlinger ◽

R. Hofheinz ◽

...

Keyword(s):

Rectal Cancer ◽

Interim Analysis ◽

Locally Advanced ◽

Disease Free Survival ◽

Advanced Rectal Cancer ◽

Free Survival ◽

Disease Free

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses

Annals of Oncology ◽

10.1093/annonc/mdw370.16 ◽

2016 ◽

Vol 27 ◽

pp. vi154 ◽

Cited By ~ 3

Author(s):

H.J. Schmoll ◽

A. Stein ◽

R.D. Hofheinz ◽

T.J. Price ◽

B. Nordlinger ◽

...

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Postoperative Chemotherapy

Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.lba3505 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. LBA3505-LBA3505 ◽

Cited By ~ 7

Author(s):

C. Roedel ◽

H. Becker ◽

R. Fietkau ◽

U. Graeven ◽

W. Hohenberger ◽

...

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase Iii ◽

Phase Iii Trial ◽

First Results

Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.3500 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3500-3500 ◽

Cited By ~ 19

Author(s):

Claus Rodel ◽

Torsten Liersch ◽

Rainer Fietkau ◽

Werner Hohenberger ◽

Ullrich Graeven ◽

...

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase Iii ◽

Phase Iii Trial

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(20)30555-6 ◽

2021 ◽

Vol 22 (1) ◽

pp. 29-42 ◽

Cited By ~ 4

Author(s):

Renu R Bahadoer ◽

Esmée A Dijkstra ◽

Boudewijn van Etten ◽

Corrie A M Marijnen ◽

Hein Putter ◽

...

Keyword(s):

Locally Advanced ◽

Advanced Rectal Cancer ◽

Mesorectal Excision ◽

Open Label ◽

Phase 3 ◽

Short Course ◽

Open Label Phase ◽

Short Course Radiotherapy